Abstract: To describe the pharmacokinetics and selected pharmacodynamic variables of codeine and its metabolites in Thoroughbred horses following a single oral administration. Methods: Prospective experimental study. Methods: A total of 12 Thoroughbred horses, nine geldings and three mares, aged 4-8 years. Methods: Horses were administered codeine (0.6 mg kg) orally and blood was collected before administration and at various times until 120 hours post administration. Plasma and urine samples were collected and analyzed for codeine and its metabolites by liquid chromatography-mass spectrometry, and plasma pharmacokinetics were determined. Heart rate and rhythm, step counts, packed cell volume and total plasma protein were measured before and 4 hours after administration. Results: Codeine was rapidly converted to the metabolites norcodeine, codeine-6-glucuronide (C6G), morphine, morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G). Plasma codeine concentrations were best represented using a two-compartment model. The C t and elimination t were 270.7 ± 136.0 ng mL, 0.438 ± 0.156 hours and 2.00 ± 0.534 hours, respectively. M3G was the main metabolite detected (C 492.7 ± 35.5 ng mL), followed by C6G (C 96.1 ± 33.8 ng mL) and M6G (C 22.3 ± 4.96 ng mL). Morphine and norcodeine were the least abundant metabolites with C of 3.17 ± 0.95 and 1.42 ± 0.79 ng mL, respectively. No significant adverse or excitatory effects were observed. Conclusions: Following oral administration, codeine is rapidly metabolized to morphine, M3G, M6G, C6G and norcodeine in horses. Plasma concentrations of M6G, a presumed active metabolite of morphine, were comparable to concentrations reported previously following administration of an analgesic dose of morphine to horses. Codeine was well tolerated based on pharmacodynamic variables and behavioral observations.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research study focuses on the metabolism, pharmacokinetics, and selected pharmacodynamic variables of Codeine in Thoroughbred horses following a single oral administration.
Research Methodology
The study recruited 12 Thoroughbred horses as test subjects, consisting of nine geldings and three mares, aged between 4-8 years.
Each horse was administered a single oral dose of Codeine.
Blood samples were collected at set intervals until 120 hours following the administration to monitor the behavior of the drug in the bloodstream.
Plasma and urine samples were then analyzed for the presence of Codeine and its metabolites using liquid chromatography-mass spectrometry, providing insight into the drug’s pharmacokinetics.
Various physiological measures, including heart rate, step counts, and packed cell volumes, were recorded before and 4 hours after Codeine administration to assess the drug’s pharmacodynamic effects.
Research Findings
Codeine was found to be rapidly metabolized into various compounds, including norcodeine, codeine-6-glucuronide (C6G), morphine, morphine-3-glucuronide (M3G), and morphine-6-glucuronide (M6G).
The drug’s presence in the plasma was best represented by a two-compartment model, implying that it is distributed in more than one area of the body.
M3G was the primary metabolite detected, followed by C6G and M6G. Morphine and norcodeine recorded the least concentrations.
No significant adverse or excitatory effects were observed post-administration, demonstrating that Codeine was well-tolerated by the horses.
Research Conclusions
Codeine is quickly transformed into morphine, M3G, M6G, C6G and norcodeine following oral administration in horses.
The plasma concentrations of M6G, an assumed active metabolite of Morphine, were comparable to concentrations previously reported after analgesic doses of Morphine were administered to horses.
Based on both the physiological measures recorded and behavioral observations, Codeine was found to be well-tolerated by the horses.
Cite This Article
APA
Gretler SR, Finno CJ, McKemie DS, Kass PH, Knych HK.
(2020).
Metabolism, pharmacokinetics and selected pharmacodynamic effects of codeine following a single oral administration to horses.
Vet Anaesth Analg, 47(5), 694-704.
https://doi.org/10.1016/j.vaa.2020.04.004
K.L. Maddy Equine Analytical Pharmacology Laboratory, University of California-Davis, School of Veterinary Medicine, Davis, CA, USA.
Finno, Carrie J
Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, CA, USA.
McKemie, Daniel S
K.L. Maddy Equine Analytical Pharmacology Laboratory, University of California-Davis, School of Veterinary Medicine, Davis, CA, USA.
Kass, Philip H
Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, CA, USA.
Knych, Heather K
K.L. Maddy Equine Analytical Pharmacology Laboratory, University of California-Davis, School of Veterinary Medicine, Davis, CA, USA; Department of Veterinary Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, USA. Electronic address: hkknych@ucdavis.edu.
MeSH Terms
Administration, Oral
Animals
Area Under Curve
Codeine / blood
Codeine / metabolism
Codeine / pharmacokinetics
Codeine / urine
Drug Administration Schedule
Female
Half-Life
Horses / metabolism
Male
Grant Funding
L40 TR001136 / NCATS NIH HHS
Conflict of Interest Statement
Conflict of interest statement. The authors declare no conflict of interest
References
This article includes 40 references
Barnett M. Alternative opioids to morphine in palliative care: a review of current practice and evidence.. Postgrad Med J 2001 Jun;77(908):371-8.
Chen ZR, Somogyi AA, Reynolds G, Bochner F. Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers.. Br J Clin Pharmacol 1991 Apr;31(4):381-90.
Findlay JW, Fowle AS, Butz RF, Jones EC, Weatherley BC, Welch RM, Posner J. Comparative disposition of codeine and pholcodine in man after single oral doses.. Br J Clin Pharmacol 1986 Jul;22(1):61-71.
Frances B, Gout R, Monsarrat B, Cros J, Zajac JM. Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.. J Pharmacol Exp Ther 1992 Jul;262(1):25-31.
Grace D, Fee JP. A comparison of intrathecal morphine-6-glucuronide and intrathecal morphine sulfate as analgesics for total hip replacement.. Anesth Analg 1996 Nov;83(5):1055-9.
Guay DR, Awni WM, Halstenson CE, Findlay JW, Opsahl JA, Abraham PA, Jones EC, Matzke GR. Pharmacokinetics of codeine after single- and multiple-oral-dose administration to normal volunteers.. J Clin Pharmacol 1987 Dec;27(12):983-7.
Yoshimura H, Mori MA, Oguri K, Tsukamoto H. Metabolism of drugs-LXV. Studies on the urinary conjugated metabolites of codeine.. Biochem Pharmacol 1970 Jul;19(7):2353-60.
Kirchheiner J, Schmidt H, Tzvetkov M, Keulen JT, Lötsch J, Roots I, Brockmöller J. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.. Pharmacogenomics J 2007 Aug;7(4):257-65.
KuKanich B. Pharmacokinetics of acetaminophen, codeine, and the codeine metabolites morphine and codeine-6-glucuronide in healthy Greyhound dogs.. J Vet Pharmacol Ther 2010 Feb;33(1):15-21.
Mama KR, Pascoe PJ, Steffey EP. Evaluation of the interaction of mu and kappa opioid agonists on locomotor behavior in the horse.. Can J Vet Res 1993 Apr;57(2):106-9.
Martins TL, Kahvegian MA, Noel-Morgan J, Leon-Román MA, Otsuki DA, Fantoni DT. Comparison of the effects of tramadol, codeine, and ketoprofen alone or in combination on postoperative pain and on concentrations of blood glucose, serum cortisol, and serum interleukin-6 in dogs undergoing maxillectomy or mandibulectomy.. Am J Vet Res 2010 Sep;71(9):1019-26.
Oguri K, Hanioka N, Yoshimura H. Species differences in metabolism of codeine: urinary excretion of codeine glucuronide, morphine-3-glucuronide and morphine-6-glucuronide in mice, rats, guinea pigs and rabbits.. Xenobiotica 1990 Jul;20(7):683-8.
Paul D, Standifer KM, Inturrisi CE, Pasternak GW. Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite.. J Pharmacol Exp Ther 1989 Nov;251(2):477-83.
Poliacek I, Simera M, Veternik M, Kotmanova Z, Bolser DC, Machac P, Jakus J. Role of the dorsomedial medulla in suppression of cough by codeine in cats.. Respir Physiol Neurobiol 2017 Dec;246:59-66.
Shimomura K, Kamata O, Ueki S, Ida S, Oguri K, Yoshimura H, Tsukamoto H. Analgesic effect of morphine glucuronides.. Tohoku J Exp Med 1971 Sep;105(1):45-52.
Stain F, Barjavel MJ, Sandouk P, Plotkine M, Scherrmann JM, Bhargava HN. Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.. J Pharmacol Exp Ther 1995 Aug;274(2):852-7.
Yoshimura H, Ida S, Oguri K, Tsukamoto H. Biochemical basis for analgesic activity of morphine-6-glucuronide. I. Penetration of morphine-6-glucuronide in the brain of rats.. Biochem Pharmacol 1973 Jun 15;22(12):1423-30.